BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22415029)

  • 1. The immninent dawn of SPRMs in obstetrics and gynecology.
    Chabbert-Buffet N; Pintiaux A; Bouchard P
    Mol Cell Endocrinol; 2012 Jul; 358(2):232-43. PubMed ID: 22415029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety.
    Bouchard P; Chabbert-Buffet N; Fauser BC
    Fertil Steril; 2011 Nov; 96(5):1175-89. PubMed ID: 21944187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms controlling agonist and antagonist potential of selective progesterone receptor modulators (SPRMs).
    Wardell SE; Edwards DP
    Semin Reprod Med; 2005 Feb; 23(1):9-21. PubMed ID: 15714386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Selective progesterone receptor modulators and their therapeutical use].
    Driák D; Sehnal B; Svandová I
    Ceska Gynekol; 2013 Apr; 78(2):175-81. PubMed ID: 23710982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone receptor antagonists.
    Spitz IM
    Curr Opin Investig Drugs; 2006 Oct; 7(10):882-90. PubMed ID: 17086932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective progesterone receptor modulators: current applications and perspectives.
    Chabbert-Buffet N; Kolanska K; Daraï E; Bouchard P
    Climacteric; 2018 Aug; 21(4):375-379. PubMed ID: 29338440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery, chemistry, and reproductive pharmacology of asoprisnil and related 11beta-benzaldoxime substituted selective progesterone receptor modulators (SPRMs).
    Schubert G; Elger W; Kaufmann G; Schneider B; Reddersen G; Chwalisz K
    Semin Reprod Med; 2005 Feb; 23(1):58-73. PubMed ID: 15714390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigational hormone receptor agonists as ongoing female contraception: a focus on selective progesterone receptor modulators in early clinical development.
    Nelson AL
    Expert Opin Investig Drugs; 2015; 24(10):1321-30. PubMed ID: 26289789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antiprogestins on the uterus.
    Ouzounian S; Bouchard P; Chabbert-Buffet N
    Womens Health (Lond); 2008 May; 4(3):269-80. PubMed ID: 19072476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Progesterone Receptor Modulators-Mechanisms and Therapeutic Utility.
    Islam MS; Afrin S; Jones SI; Segars J
    Endocr Rev; 2020 Oct; 41(5):. PubMed ID: 32365199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of progesterone antagonists and new selective progesterone receptor modulators in reproductive health.
    Olive DL
    Obstet Gynecol Surv; 2002 Nov; 57(11 Suppl 4):S55-63. PubMed ID: 12454529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective progesterone receptor modulators and reproductive health.
    Nieman LK
    Curr Opin Endocrinol Diabetes Obes; 2022 Aug; 29(4):406-412. PubMed ID: 35776850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Selective progesterone receptor modulators: future clinical applications].
    Bouchard P; Ouzounian S; Chabbert-Buffet N
    Bull Acad Natl Med; 2008; 192(6):1159-71; discussion 1172-3. PubMed ID: 19235480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone receptor antagonists and the endometrial antiproliferative effect.
    Brenner RM; Slayden OD
    Semin Reprod Med; 2005 Feb; 23(1):74-81. PubMed ID: 15714391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The state-of-the-art of emergency contraception with the cutting edge drug.
    Sarkar NN
    Ger Med Sci; 2011; 9():Doc16. PubMed ID: 21808601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone receptor antagonists and selective progesterone receptor modulators (SPRMs).
    Spitz IM
    Semin Reprod Med; 2005 Feb; 23(1):3-7. PubMed ID: 15714385
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonsteroidal progesterone receptor modulators: structure activity relationships.
    Winneker RC; Fensome A; Wrobel JE; Zhang Z; Zhang P
    Semin Reprod Med; 2005 Feb; 23(1):46-57. PubMed ID: 15714389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Molecular Changes in Endometrium Associated With Chronic Use of Progesterone Receptor Modulators: Ulipristal Acetate Versus Mifepristone.
    Kannan A; Bhurke A; Sitruk-Ware R; Lalitkumar PG; Gemzell-Danielsson K; Williams ARW; Taylor RN; Bagchi MK; Bagchi IC
    Reprod Sci; 2018 Mar; 25(3):320-328. PubMed ID: 29241443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gynaecological uses of a new class of steroids: the selective progesterone receptor modulators.
    Pintiaux A; Chabbert-Buffet N; Foidart JM
    Gynecol Endocrinol; 2009 Feb; 25(2):67-73. PubMed ID: 19253100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications.
    Chabbert-Buffet N; Meduri G; Bouchard P; Spitz IM
    Hum Reprod Update; 2005; 11(3):293-307. PubMed ID: 15790602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.